Generate Biomedicines’ IPO Brings In $400M for Pivotal Tests of Severe Asthma Drug
Flagship Pioneering-founded Generate Biomedicines aims to offer less frequent injections compared to a blockbuster asthma…
Flagship Pioneering-founded Generate Biomedicines aims to offer less frequent injections compared to a blockbuster asthma drug from partners Amgen and AstraZeneca. Generate’s drug comes from a “programable biology” platform technology that uses AI and machine learning to design proteins with desirable properties. The post Generate Biomedicines’ IPO Brings In $400M for Pivotal Tests of Severe…
Last year, as the California hospital where she worked was appeasing the Trump administration by erasing words like “equity” and “diversity” from its paperwork, Brandy Frye had seen enough. Frye, an emergency room nurse with 25 years of experience, felt that ignoring inequality’s role in health and sickness was an affront to the compassionate soul…
Healthcare providers need to be thinking not only about the experience that patients need and want now, but the experience they’re going to need and want down the road. The post Where the Patient Experience Is Heading – And 3 Ways Healthcare Providers Can Meet That Moment appeared first on MedCity News.
Any regulations applied won’t be as simple as putting on a Band-Aid and forgetting about future problems. To regulate appropriately, we need to learn from the past and act quickly as AI is rapidly incorporated into healthcare. The post Regulating Healthcare AI? Look To E-Prescribing appeared first on MedCity News.
Over the course of 2025, Jayant Mishra of Mission Viejo, California, progressively developed scaly, itchy red patches on his skin. Then came the pain and swelling in the joints of his hands, making it difficult to do his work at a bank. His primary care doctor referred him to a rheumatologist, who diagnosed psoriatic arthritis….
A woman with multiple sclerosis wanted to be able to walk up the stairs at home without losing her balance. Her doctor prescribed medicine that helped, but then approval from her insurance plan for the drug expired. “Why do I need a prior authorization for something that I am already prior-authorized to take? If my…
Ratnakar Lavu, Elevance Health’s chief digital information officer, said the company is using AI to streamline approvals, claims processing and member support while keeping denials under human review. The post How Elevance Health Is — and Isn’t — Using AI appeared first on MedCity News.
The label expansion for Boehringer Ingelheim’s Hernexeos was made under an FDA pilot program that accelerates regulatory review of products with national interest. The daily pill is now approved as a first-line treatment for HER2-positive non-small lung cancer, an indication with few treatment options. The post FDA Voucher Leads to Speedy Approval of Boehringer Drug…
Collective Health partnered with Google Cloud to launch an AI-powered system that helps members navigate benefits and streamlines plan administration for employers. The post Collective Health Collaborates with Google Cloud to Launch New AI-Powered System appeared first on MedCity News.
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…